|
|
| VUL501 | 外阴肿瘤及正常组织组合芯片，附病理分级、TNM和临床分期，50例/50点 | | 点 数 | 50 | 例 数 | 50 | | 行 数 | 6 | 列 数 | 9 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
* (*) Malignant (0.0) Malignant (I) Malignant (IB) Malignant (II) Malignant (IIIA) Malignant (IVA) NAT (*) Normal (*) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 50 | F | Vulva | Carcinoma in situ | 1 | TisN0M0 | 0.0 | Malignant | N |
| A2 | 2 | 57 | F | Vulva | Squamous cell carcinoma | 1 | T1bN0M0 | IB | Malignant | N |
| A3 | 3 | 67 | F | Vulva | Squamous cell carcinoma | 1 | T1bN0M0 | IB | Malignant | N |
| A4 | 4 | 70 | F | Vulva | Squamous cell carcinoma | 1 | T3N2M0 | IVA | Malignant | N |
| A5 | 5 | 70 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| A6 | 6 | 77 | F | Vulva | Squamous cell carcinoma | 1 | T3N1M0 | IVA | Malignant | N |
| A7 | 7 | 36 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| A8 | 8 | 74 | F | Vulva | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | N |
| A9 | 9 | * | * | Blank | Blank | * | * | * | * | N |
| B1 | 10 | 55 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| B2 | 11 | 69 | F | Vulva | Squamous cell carcinoma | 1 | T2N1M0 | IIIA | Malignant | N |
| B3 | 12 | 64 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| B4 | 13 | 65 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| B5 | 14 | 68 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| B6 | 15 | 54 | F | Vulva | Squamous cell carcinoma | 1 | T3N1M0 | IVA | Malignant | N |
| B7 | 16 | 46 | F | Vulva | Squamous cell carcinoma | 1 | T3N2M0 | IVA | Malignant | N |
| B8 | 17 | 61 | F | Vulva | Squamous cell carcinoma (sparse) | 1 | T1N0M0 | I | Malignant | N |
| B9 | 18 | * | * | Blank | Blank | * | * | * | * | N |
| C1 | 19 | 77 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| C2 | 20 | 50 | F | Vulva | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | N |
| C3 | 21 | 43 | F | Vulva | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | N |
| C4 | 22 | 69 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| C5 | 23 | 52 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| C6 | 24 | 53 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| C7 | 25 | 48 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| C8 | 26 | 42 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| C9 | 27 | * | * | Blank | Blank | * | * | * | * | N |
| D1 | 28 | 54 | F | Vulva | Squamous cell carcinoma | 1 | T1bN0M0 | IB | Malignant | N |
| D2 | 29 | 49 | F | Vulva | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | N |
| D3 | 30 | 58 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| D4 | 31 | 88 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| D5 | 32 | 40 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| D6 | 33 | 73 | F | Vulva | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | N |
| D7 | 34 | 87 | F | Vulva | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | N |
| D8 | 35 | 46 | F | Vulva | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | N |
| D9 | 36 | * | * | Blank | Blank | * | * | * | * | N |
| E1 | 37 | 58 | F | Vulva | Squamous cell carcinoma | 1--2 | T2N0M0 | II | Malignant | N |
| E2 | 38 | 55 | F | Vulva | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant | N |
| E3 | 39 | 72 | F | Vulva | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E4 | 40 | 81 | F | Vulva | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E5 | 41 | 58 | F | Vulva | Squamous cell carcinoma | 3 | T2N0M0 | II | Malignant | N |
| E6 | 42 | 76 | F | Vulva | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E7 | 43 | 47 | F | Vulva | Warty carcinoma | * | T3N0M0 | IVA | Malignant | N |
| E8 | 44 | 75 | F | Vulva | Warty carcinoma | * | T3N1M0 | IVA | Malignant | N |
| E9 | 45 | 70 | F | Vulva | Warty carcinoma | * | T1N0M0 | I | Malignant | N |
| F1 | 46 | 45 | F | Vulva | Adjacent normal vulva tissue | * | * | * | NAT | N |
| F2 | 47 | 44 | F | Vulva | Adjacent normal vulva tissue | * | * | * | NAT | N |
| F3 | 48 | 47 | F | Vulva | Adjacent normal vulva tissue (fibrous and blood vessal tissue) | * | * | * | NAT | N |
| F4 | 49 | 53 | F | Vulva | Adjacent normal vulva tissue | * | * | * | NAT | N |
| F5 | 50 | 29 | F | Vulva | Adjacent normal vulva tissue | * | * | * | NAT | N |
| F6 | 51 | 52 | F | Vulva | Adjacent normal vulva tissue (fibrous and blood vessal tissue) | * | * | * | NAT | N |
| F7 | 52 | 45 | F | Vulva | Adjacent normal vulva tissue | * | * | * | NAT | N |
| F8 | 53 | 51 | F | Vulva | Adjacent normal vulva tissue | * | * | * | NAT | N |
| F9 | 54 | 49 | F | Vulva | Vulva tissue | * | * | * | Normal | N |
|
